Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Herpesvirus 8, Human | 39 | 2024 | 258 | 10.900 |
Why?
|
Antigens, Viral | 37 | 2024 | 1035 | 6.810 |
Why?
|
Sarcoma, Kaposi | 15 | 2024 | 370 | 4.230 |
Why?
|
Nuclear Proteins | 34 | 2024 | 5853 | 3.700 |
Why?
|
Virus Latency | 17 | 2024 | 358 | 3.560 |
Why?
|
Plasmids | 17 | 2020 | 2307 | 3.400 |
Why?
|
DNA, Viral | 25 | 2021 | 2225 | 2.610 |
Why?
|
Terminal Repeat Sequences | 13 | 2019 | 72 | 2.540 |
Why?
|
DNA Replication | 13 | 2019 | 1399 | 1.650 |
Why?
|
Gene Expression Regulation, Viral | 6 | 2024 | 442 | 1.430 |
Why?
|
Rhadinovirus | 7 | 2018 | 37 | 1.220 |
Why?
|
Virus Replication | 11 | 2024 | 2534 | 1.190 |
Why?
|
Chromosomes | 7 | 2019 | 596 | 1.050 |
Why?
|
Nucleosomes | 4 | 2014 | 494 | 0.840 |
Why?
|
Genome, Viral | 7 | 2020 | 667 | 0.790 |
Why?
|
Herpesviridae Infections | 6 | 2019 | 277 | 0.730 |
Why?
|
Herpesvirus 4, Human | 11 | 2016 | 1041 | 0.720 |
Why?
|
Mitosis | 8 | 2019 | 1208 | 0.690 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2021 | 294 | 0.670 |
Why?
|
Ganciclovir | 1 | 2019 | 258 | 0.670 |
Why?
|
Viral Matrix Proteins | 8 | 1999 | 186 | 0.660 |
Why?
|
Germinal Center | 2 | 2017 | 377 | 0.610 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2021 | 670 | 0.600 |
Why?
|
Chromosomes, Human | 4 | 2011 | 457 | 0.590 |
Why?
|
Opportunistic Infections | 1 | 2019 | 389 | 0.560 |
Why?
|
beta-Lactams | 2 | 2009 | 160 | 0.530 |
Why?
|
Cell Transformation, Viral | 9 | 2020 | 565 | 0.530 |
Why?
|
Replication Protein C | 1 | 2014 | 19 | 0.510 |
Why?
|
Antiviral Agents | 2 | 2019 | 2987 | 0.490 |
Why?
|
B-Lymphocytes | 12 | 2023 | 4665 | 0.490 |
Why?
|
Cytomegalovirus Infections | 1 | 2019 | 820 | 0.440 |
Why?
|
Host-Pathogen Interactions | 6 | 2021 | 1477 | 0.400 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 1170 | 0.380 |
Why?
|
Herpesvirus 6, Human | 1 | 2011 | 95 | 0.380 |
Why?
|
Viral Proteins | 7 | 2019 | 1900 | 0.370 |
Why?
|
Lymphoma, Primary Effusion | 2 | 2020 | 17 | 0.340 |
Why?
|
Tumor Virus Infections | 3 | 2020 | 452 | 0.340 |
Why?
|
Protein Binding | 12 | 2021 | 9386 | 0.340 |
Why?
|
Cell Line, Tumor | 11 | 2021 | 16689 | 0.320 |
Why?
|
Virulence Factors | 1 | 2011 | 509 | 0.310 |
Why?
|
Cell Line | 14 | 2019 | 15997 | 0.280 |
Why?
|
Proliferating Cell Nuclear Antigen | 2 | 2019 | 285 | 0.270 |
Why?
|
Centromere | 1 | 2006 | 220 | 0.260 |
Why?
|
Anti-Bacterial Agents | 4 | 2009 | 7181 | 0.260 |
Why?
|
Histones | 5 | 2020 | 2599 | 0.250 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2019 | 2425 | 0.250 |
Why?
|
Crystallography, X-Ray | 3 | 2021 | 2011 | 0.240 |
Why?
|
Protein Conformation | 4 | 2021 | 4011 | 0.240 |
Why?
|
Gene Knockdown Techniques | 2 | 2021 | 1655 | 0.230 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2021 | 2915 | 0.230 |
Why?
|
Antigens, Nuclear | 2 | 2019 | 192 | 0.230 |
Why?
|
Enhancer Elements, Genetic | 2 | 2020 | 1341 | 0.210 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2021 | 2942 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-myc | 3 | 2020 | 987 | 0.210 |
Why?
|
S-Phase Kinase-Associated Proteins | 1 | 2021 | 90 | 0.200 |
Why?
|
DNA | 2 | 2024 | 7301 | 0.200 |
Why?
|
Cell Nucleus | 4 | 2019 | 2969 | 0.190 |
Why?
|
Binding Sites | 8 | 2018 | 6114 | 0.190 |
Why?
|
DNA-Binding Proteins | 5 | 2018 | 9648 | 0.180 |
Why?
|
Humans | 60 | 2024 | 744343 | 0.180 |
Why?
|
Viral Load | 3 | 2019 | 3299 | 0.180 |
Why?
|
Electrophoretic Mobility Shift Assay | 2 | 2013 | 300 | 0.180 |
Why?
|
Biosensing Techniques | 2 | 2016 | 668 | 0.170 |
Why?
|
Molecular Sequence Data | 11 | 2013 | 18111 | 0.170 |
Why?
|
NF-kappa B | 6 | 1999 | 2499 | 0.170 |
Why?
|
Bacterial Infections | 3 | 2009 | 1401 | 0.170 |
Why?
|
Pulmonary Fibrosis | 1 | 2023 | 530 | 0.160 |
Why?
|
Protein Folding | 3 | 2013 | 843 | 0.160 |
Why?
|
Lymphoma, B-Cell | 2 | 2016 | 931 | 0.160 |
Why?
|
Adenosine Kinase | 1 | 2017 | 12 | 0.150 |
Why?
|
Purine Nucleosides | 1 | 2017 | 30 | 0.150 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2023 | 451 | 0.150 |
Why?
|
Cell Cycle Proteins | 4 | 2019 | 3462 | 0.150 |
Why?
|
Tumor Cells, Cultured | 6 | 2013 | 6314 | 0.150 |
Why?
|
Promoter Regions, Genetic | 3 | 2020 | 5867 | 0.150 |
Why?
|
Mutation | 8 | 2015 | 29786 | 0.140 |
Why?
|
Virus Diseases | 1 | 2023 | 711 | 0.140 |
Why?
|
Lymphoma | 3 | 2002 | 1877 | 0.140 |
Why?
|
Recombination, Genetic | 5 | 2013 | 1586 | 0.140 |
Why?
|
Protein Structure, Tertiary | 6 | 2015 | 3846 | 0.140 |
Why?
|
Amino Acid Sequence | 8 | 2018 | 13815 | 0.140 |
Why?
|
Base Sequence | 7 | 2011 | 12797 | 0.140 |
Why?
|
HEK293 Cells | 3 | 2020 | 4204 | 0.130 |
Why?
|
DNA-Directed DNA Polymerase | 2 | 2019 | 486 | 0.130 |
Why?
|
Pulmonary Embolism | 2 | 2023 | 2376 | 0.130 |
Why?
|
Clarithromycin | 1 | 1995 | 86 | 0.130 |
Why?
|
Static Electricity | 1 | 2015 | 267 | 0.130 |
Why?
|
Microscopy, Fluorescence | 2 | 2013 | 2699 | 0.130 |
Why?
|
DNA Repair | 1 | 2024 | 2046 | 0.120 |
Why?
|
Electricity | 1 | 2015 | 182 | 0.120 |
Why?
|
Dimerization | 2 | 2006 | 893 | 0.120 |
Why?
|
Azithromycin | 1 | 1995 | 196 | 0.120 |
Why?
|
Fluorescence Polarization | 1 | 2014 | 132 | 0.120 |
Why?
|
Monocytes | 1 | 2023 | 2596 | 0.120 |
Why?
|
Chromatin | 3 | 2013 | 2934 | 0.110 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2015 | 214 | 0.110 |
Why?
|
Gene Expression | 2 | 2024 | 7799 | 0.110 |
Why?
|
Anti-Infective Agents, Local | 1 | 1995 | 250 | 0.110 |
Why?
|
Lymphoproliferative Disorders | 1 | 2016 | 523 | 0.110 |
Why?
|
Gram-Negative Aerobic Bacteria | 1 | 1992 | 8 | 0.110 |
Why?
|
Animals | 19 | 2021 | 168757 | 0.110 |
Why?
|
Half-Life | 1 | 2013 | 661 | 0.110 |
Why?
|
Proteins | 6 | 1999 | 6103 | 0.100 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1708 | 0.100 |
Why?
|
Fever | 1 | 2019 | 1616 | 0.100 |
Why?
|
Chickens | 1 | 2014 | 865 | 0.100 |
Why?
|
Glutathione Transferase | 1 | 2014 | 595 | 0.100 |
Why?
|
Spectrometry, Fluorescence | 1 | 2014 | 689 | 0.100 |
Why?
|
Headache | 1 | 2019 | 1226 | 0.100 |
Why?
|
Amino Acid Substitution | 2 | 2007 | 1791 | 0.100 |
Why?
|
DNA Primers | 3 | 2013 | 2892 | 0.100 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2015 | 428 | 0.090 |
Why?
|
Chromosome Segregation | 1 | 2011 | 235 | 0.090 |
Why?
|
Cell Survival | 3 | 2017 | 5882 | 0.090 |
Why?
|
Nanostructures | 1 | 2015 | 551 | 0.090 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 1992 | 232 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 3870 | 0.090 |
Why?
|
Proteomics | 1 | 2023 | 3638 | 0.090 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2016 | 1861 | 0.090 |
Why?
|
Cell Division | 4 | 2011 | 4568 | 0.090 |
Why?
|
Thallium Radioisotopes | 1 | 1989 | 139 | 0.090 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1678 | 0.080 |
Why?
|
TNF Receptor-Associated Factor 2 | 6 | 1999 | 59 | 0.080 |
Why?
|
Mice | 10 | 2021 | 81183 | 0.080 |
Why?
|
Models, Molecular | 3 | 2015 | 5456 | 0.080 |
Why?
|
Flow Cytometry | 3 | 2015 | 5974 | 0.080 |
Why?
|
Ubiquitination | 1 | 2013 | 1012 | 0.080 |
Why?
|
HeLa Cells | 2 | 2014 | 3128 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8428 | 0.080 |
Why?
|
Macrophages | 1 | 2023 | 5655 | 0.080 |
Why?
|
Genomic Instability | 1 | 2013 | 695 | 0.080 |
Why?
|
Drug Design | 1 | 2014 | 1076 | 0.080 |
Why?
|
Antigens | 1 | 2014 | 1466 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 944 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3597 | 0.070 |
Why?
|
Catheterization, Central Venous | 1 | 1992 | 514 | 0.070 |
Why?
|
Mammalian orthoreovirus 3 | 1 | 1986 | 44 | 0.070 |
Why?
|
COS Cells | 2 | 2007 | 1161 | 0.070 |
Why?
|
Immunocompromised Host | 1 | 1992 | 847 | 0.070 |
Why?
|
Hemagglutinins, Viral | 1 | 1986 | 67 | 0.070 |
Why?
|
Alanine | 1 | 2009 | 572 | 0.070 |
Why?
|
Genome, Human | 1 | 2020 | 4420 | 0.070 |
Why?
|
Polymerase Chain Reaction | 3 | 2011 | 6171 | 0.070 |
Why?
|
Reoviridae | 1 | 1986 | 161 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2014 | 1917 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4751 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 1996 | 2916 | 0.070 |
Why?
|
Blotting, Western | 1 | 2013 | 5179 | 0.070 |
Why?
|
MicroRNAs | 1 | 2021 | 3752 | 0.070 |
Why?
|
Chromosomes, Mammalian | 1 | 2006 | 151 | 0.060 |
Why?
|
Cell Proliferation | 2 | 2020 | 10481 | 0.060 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 1 | 2004 | 30 | 0.060 |
Why?
|
Erythrocytes | 1 | 2014 | 2455 | 0.060 |
Why?
|
Immunoprecipitation | 1 | 2007 | 905 | 0.060 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2006 | 440 | 0.060 |
Why?
|
Genomics | 1 | 2020 | 5720 | 0.060 |
Why?
|
Lactams | 1 | 2004 | 156 | 0.060 |
Why?
|
Cephalosporins | 1 | 2004 | 204 | 0.060 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2007 | 1723 | 0.060 |
Why?
|
Genes, Viral | 2 | 1999 | 718 | 0.060 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2007 | 635 | 0.060 |
Why?
|
Base Composition | 1 | 2002 | 293 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 1993 | 5524 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2015 | 4386 | 0.050 |
Why?
|
Xenopus laevis | 1 | 2006 | 957 | 0.050 |
Why?
|
Exercise Test | 1 | 1989 | 2074 | 0.050 |
Why?
|
Lymphocytes | 2 | 1999 | 2617 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 3 | 5 | 1999 | 40 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 1 | 5 | 1999 | 50 | 0.050 |
Why?
|
Immunity, Cellular | 1 | 2007 | 1607 | 0.050 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2002 | 798 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2001 | 829 | 0.050 |
Why?
|
Aminoglycosides | 1 | 2000 | 162 | 0.040 |
Why?
|
Cosmids | 1 | 1999 | 107 | 0.040 |
Why?
|
Herpesvirus 2, Saimiriine | 1 | 1999 | 61 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2002 | 2050 | 0.040 |
Why?
|
Child | 3 | 2023 | 77709 | 0.040 |
Why?
|
Interferon Regulatory Factors | 1 | 2020 | 270 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 2 | 2006 | 3772 | 0.040 |
Why?
|
Interphase | 1 | 1999 | 226 | 0.040 |
Why?
|
Bacteria | 1 | 2009 | 2114 | 0.040 |
Why?
|
Nucleic Acid Conformation | 2 | 2015 | 913 | 0.040 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2006 | 1581 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2013 | 13033 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2004 | 3129 | 0.040 |
Why?
|
Virus Integration | 1 | 2020 | 299 | 0.040 |
Why?
|
RNA Splicing | 1 | 2002 | 907 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2019 | 63114 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 452 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 809 | 0.040 |
Why?
|
Acetylation | 1 | 2020 | 1085 | 0.040 |
Why?
|
HIV-1 | 1 | 2015 | 6939 | 0.040 |
Why?
|
Phenotype | 2 | 2009 | 16365 | 0.040 |
Why?
|
Oncogene Proteins, Viral | 1 | 1999 | 362 | 0.040 |
Why?
|
3T3 Cells | 1 | 2018 | 1101 | 0.040 |
Why?
|
Fibroblasts | 2 | 1999 | 4161 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 1 | 2017 | 459 | 0.030 |
Why?
|
Pyoderma | 1 | 1995 | 8 | 0.030 |
Why?
|
Transfection | 3 | 1999 | 5892 | 0.030 |
Why?
|
Peptides | 1 | 2007 | 4409 | 0.030 |
Why?
|
Binding, Competitive | 1 | 1996 | 1157 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1912 | 0.030 |
Why?
|
Mice, Nude | 1 | 2021 | 3689 | 0.030 |
Why?
|
Spleen | 2 | 2015 | 2362 | 0.030 |
Why?
|
Virus Activation | 1 | 2016 | 319 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 1997 | 595 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 1999 | 1285 | 0.030 |
Why?
|
Limit of Detection | 1 | 2015 | 265 | 0.030 |
Why?
|
DNA, Recombinant | 1 | 1995 | 476 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2016 | 500 | 0.030 |
Why?
|
Osmolar Concentration | 1 | 2015 | 683 | 0.030 |
Why?
|
Coronary Disease | 1 | 1989 | 6077 | 0.030 |
Why?
|
Thermodynamics | 1 | 2015 | 596 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13695 | 0.030 |
Why?
|
Antigens, Ly | 1 | 2015 | 291 | 0.030 |
Why?
|
Endonucleases | 1 | 2016 | 380 | 0.030 |
Why?
|
Cytoplasm | 2 | 1996 | 1539 | 0.030 |
Why?
|
Enzyme Activation | 1 | 1999 | 3701 | 0.030 |
Why?
|
Wound Infection | 1 | 1995 | 242 | 0.030 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2013 | 143 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 1999 | 1970 | 0.030 |
Why?
|
Codon | 1 | 1995 | 611 | 0.030 |
Why?
|
Blotting, Southern | 1 | 1993 | 803 | 0.030 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2013 | 279 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2017 | 1878 | 0.030 |
Why?
|
Bromodeoxyuridine | 1 | 2013 | 322 | 0.030 |
Why?
|
Phylogeny | 1 | 2020 | 2803 | 0.030 |
Why?
|
Adult | 4 | 2019 | 214055 | 0.030 |
Why?
|
Drug Resistance, Microbial | 1 | 1995 | 862 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 1993 | 898 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2000 | 4933 | 0.030 |
Why?
|
F-Box Proteins | 1 | 2013 | 197 | 0.030 |
Why?
|
Mice, SCID | 1 | 2017 | 2716 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 1 | 2013 | 643 | 0.030 |
Why?
|
Protein Stability | 1 | 2013 | 557 | 0.020 |
Why?
|
Reference Standards | 1 | 2015 | 1025 | 0.020 |
Why?
|
Female | 6 | 2023 | 380194 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 1993 | 433 | 0.020 |
Why?
|
Acne Vulgaris | 1 | 1995 | 302 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 21683 | 0.020 |
Why?
|
HIV Infections | 2 | 2015 | 16718 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2015 | 2557 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2015 | 970 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 1993 | 1246 | 0.020 |
Why?
|
Open Reading Frames | 1 | 1993 | 810 | 0.020 |
Why?
|
Immunoblotting | 1 | 1993 | 1682 | 0.020 |
Why?
|
Catheterization | 1 | 1995 | 1470 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2013 | 893 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 21827 | 0.020 |
Why?
|
Microfluidics | 1 | 2015 | 662 | 0.020 |
Why?
|
Th1 Cells | 1 | 2015 | 1057 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4217 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2007 | 10180 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3557 | 0.020 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2015 | 570 | 0.020 |
Why?
|
Environment | 1 | 2015 | 1124 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2015 | 14557 | 0.020 |
Why?
|
Temperature | 1 | 2015 | 2206 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2002 | 7722 | 0.020 |
Why?
|
Respiratory Tract Infections | 1 | 1995 | 961 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 1996 | 6622 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4186 | 0.020 |
Why?
|
Computational Biology | 1 | 2020 | 3521 | 0.020 |
Why?
|
Interleukin-6 | 1 | 1997 | 3200 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3582 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2016 | 2564 | 0.020 |
Why?
|
Callithrix | 2 | 1999 | 93 | 0.020 |
Why?
|
Reoviridae Infections | 1 | 1986 | 60 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2015 | 1177 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2015 | 3206 | 0.020 |
Why?
|
Cardiomegaly | 1 | 1989 | 620 | 0.020 |
Why?
|
Epitopes | 2 | 2007 | 2571 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 20947 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 12951 | 0.020 |
Why?
|
Macromolecular Substances | 1 | 2007 | 1454 | 0.020 |
Why?
|
Heart Transplantation | 1 | 1998 | 3110 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 1989 | 2031 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14722 | 0.020 |
Why?
|
Surface Properties | 1 | 2007 | 1184 | 0.020 |
Why?
|
Lung | 1 | 2023 | 9856 | 0.020 |
Why?
|
Neutralization Tests | 1 | 1986 | 758 | 0.020 |
Why?
|
Burns | 1 | 1995 | 1815 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1999 | 19229 | 0.010 |
Why?
|
Cell Membrane | 1 | 1993 | 3748 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10262 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 4420 | 0.010 |
Why?
|
Transcription Factors | 2 | 2016 | 12208 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2015 | 9734 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5172 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2007 | 1880 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4479 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2015 | 2988 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2020 | 15519 | 0.010 |
Why?
|
Immunologic Memory | 1 | 2007 | 1348 | 0.010 |
Why?
|
Aotidae | 1 | 1999 | 59 | 0.010 |
Why?
|
Brain | 1 | 1986 | 26385 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2013 | 5021 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9727 | 0.010 |
Why?
|
Infant | 1 | 2000 | 35136 | 0.010 |
Why?
|
Male | 5 | 2019 | 350118 | 0.010 |
Why?
|
Genome | 1 | 2006 | 1808 | 0.010 |
Why?
|
Pleural Effusion, Malignant | 1 | 1998 | 101 | 0.010 |
Why?
|
HIV Seronegativity | 1 | 1998 | 211 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2015 | 11483 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 19905 | 0.010 |
Why?
|
Intestines | 1 | 1986 | 1924 | 0.010 |
Why?
|
Heart Ventricles | 1 | 1989 | 3821 | 0.010 |
Why?
|
United States | 1 | 2004 | 69872 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 77449 | 0.010 |
Why?
|
Mutagenesis | 1 | 1999 | 1266 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1989 | 12959 | 0.010 |
Why?
|
Epithelium | 1 | 1997 | 1679 | 0.010 |
Why?
|
Sequence Deletion | 1 | 1997 | 1526 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1996 | 2839 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1996 | 1783 | 0.010 |
Why?
|
Child, Preschool | 1 | 1992 | 41006 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1996 | 2126 | 0.010 |
Why?
|
Kinetics | 1 | 1996 | 6473 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1997 | 2245 | 0.000 |
Why?
|
Time Factors | 1 | 1986 | 40075 | 0.000 |
Why?
|
Hematopoietic Stem Cells | 1 | 1997 | 3386 | 0.000 |
Why?
|
Rats | 1 | 1999 | 24260 | 0.000 |
Why?
|
Ovarian Neoplasms | 1 | 1997 | 4838 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 1996 | 12072 | 0.000 |
Why?
|
Aged | 1 | 1989 | 163280 | 0.000 |
Why?
|
Middle Aged | 1 | 1998 | 213383 | 0.000 |
Why?
|